C

Citius Pharmaceuticals
D

CTXR

0.13370
USD
-0.00
(-0.22%)
Market Closed
Volume
2,960,912
EPS
-0
Div Yield
-
P/E
-1
Market Cap
25,767,387
OverviewSignalsIdeasNews
Related Instruments
    A
    ACRX
    0
    (0%)
    0.000000 USD
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    ASRT
    -0.03000
    (-3.57%)
    0.81000 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    E
    EIGR
    0
    (0%)
    0.000000 USD
    E
    EPIX
    -0.04000
    (-2.27%)
    1.72500 USD
    M
    MTEM
    -0.14200
    (-23.67%)
    0.45800 USD
    More
News

Title: Citius Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for thetreatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.